作者
Sam Straw, Wazir Baig, Jianhua Wu, Jonathan Sandoe
发表日期
2019/5/1
来源
Heart
卷号
105
期号
Suppl 6
页码范围
A106-A106
出版商
BMJ Publishing Group Ltd and British Cardiovascular Society
简介
Background
Intravenous drug use (IVDU) is a predisposition for the development of infective endocarditis (IE). The incidence amongst people who inject drugs (PWID) is estimated to be 50–100 times greater than the general population. For this reason, PWID with symptoms of infection or bacteraemia are frequently referred to the IE team for assessment. We have previously reported on our experience of managing PWID with IE over more than a decade. Here we present the characteristics, final diagnoses and outcomes in all PWID admitted to hospital with other infections in whom IE was suspected.
Methods
Patients aged 18 or over who had taken drugs intravenously within 90 days and referred to the IE team between 01/01/2006 and 31/12/2016 were eligible. Inclusion was dependent on the modified Duke criteria, we required patients to be either Duke criteria negative, or Duke possible and not treated for IE …